Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CBX7 | O95931 | 3/20 | 0.38 |
| ▸ | CDYL2 | Q8N8U2 | 3/20 | 0.38 |
| ▸ | CDYL | Q9Y232 | 3/20 | 0.38 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3772647 | 0.87 | ALDH1A1 (0.44) | KDM4EALDH1A1PARP1HRH3MAPT | |
| SCHEMBL3768031 | 0.83 | ALDH1A1 (0.47) | KDM4EALDH1A1PARP1HRH3 | |
| SCHEMBL13060869 | 0.79 | GAA (0.38) | KDM4EALDH1A1PARP1HRH3TSHR | |
| SCHEMBL3774344 | 0.78 | EGLN1 (0.44) | KDM4EALDH1A1PARP1 | |
| SCHEMBL3770771 | 0.78 | SIGMAR1 (0.51) | KDM4EALDH1A1PARP1HRH3 | |
| SCHEMBL3767757 | 0.77 | HRH3 (0.49) | KDM4EALDH1A1PARP1HRH3MAPT | |
| SCHEMBL3773917 | 0.77 | ALDH1A1 (0.45) | KDM4EALDH1A1MAPTTSHRNPSR1 | |
| SCHEMBL13006746 | 0.77 | OPRL1 (0.51) | KDM4EALDH1A1HRH3CYP2C9CYP2C19 | |
| SCHEMBL3767749 | 0.76 | SIGMAR1 (0.51) | KDM4EALDH1A1PARP1HRH3MAPT | |
| SCHEMBL3771973 | 0.76 | ALDH1A1 (0.46) | KDM4EALDH1A1PARP1HRH3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851474-B2 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION (US) | 2010-12-14 | — | — | US | disclosed |
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION | 2007-03-01 | — | — | US | disclosed |
| WO-2007016496-A2 | DIPIPERAZINYL KETONES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2007-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | HRH4, HRH3, HRH1 | KDM4E 534/4885ALDH1A1 1210/4885PARP1 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.